Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 2,630,000 | $1.56B | 15.34% | NEW | — | $592.98 | -2.9% |
| 2 | ASNDUSD | ASCENDIS PHARMA | — | 5,062,500 | $1.16B | 11.39% | NEW | — | $228.73 | — |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,818,181 | $951.8M | 9.36% | NEW | — | $523.47 | +3.1% |
| 4 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 2,888,888 | $746.3M | 7.34% | NEW | — | $258.32 | +22.4% |
| 5 | ARGX | ARGENX SE | Healthcare | 1,000,000 | $730.2M | 7.18% | NEW | — | $730.25 | +9.5% |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | 10,699,999 | $670.9M | 6.60% | NEW | — | $62.70 | +22.3% |
| 7 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 7,474,747 | $622.6M | 6.12% | NEW | — | $83.29 | +1.5% |
| 8 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 12,222,222 | $491.7M | 4.84% | NEW | — | $40.23 | +2.0% |
| 9 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 11,430,455 | $454.0M | 4.47% | NEW | — | $39.72 | -0.3% |
| 10 | CELC | CELCUITY INC | Healthcare | 3,375,000 | $385.2M | 3.79% | NEW | — | $114.14 | +20.6% |
| 11 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 5,777,777 | $336.0M | 3.31% | NEW | — | $58.15 | -3.7% |
| 12 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 6,555,555 | $316.0M | 3.11% | NEW | — | $48.20 | -17.3% |
| 13 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 5,695,000 | $300.2M | 2.95% | NEW | — | $52.72 | +0.4% |
| 14 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,888,888 | $236.9M | 2.33% | NEW | — | $40.23 | -1.7% |
| 15 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 2,344,444 | $228.0M | 2.24% | NEW | — | $97.25 | +53.7% |
| 16 | CYTK | CYTOKINETICS INC | Healthcare | 3,333,333 | $219.7M | 2.16% | NEW | — | $65.91 | +19.3% |
| 17 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 12,315,000 | $104.3M | 1.03% | NEW | — | $8.47 | +12.2% |
| 18 | DMRA | DAMORA THERAPEUTICS INC | Healthcare | 3,783,000 | $98.0M | 0.96% | NEW | — | $25.90 | -7.8% |
| 19 | QURE | UNIQURE NV | Healthcare | 5,959,595 | $97.4M | 0.96% | NEW | — | $16.35 | +69.7% |
| 20 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 21,700,000 | $97.0M | 0.95% | NEW | — | $4.47 | +40.9% |
| 21 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 5,000,000 | $94.5M | 0.93% | NEW | — | $18.90 | +13.0% |
| 22 | SLNO | SOLENO THERAPEUTICS INC | Healthcare | 2,300,000 | $77.0M | 0.76% | NEW | — | $33.48 | +58.3% |
| 23 | ALKS | ALKERMES PLC | Healthcare | 1,200,000 | $42.4M | 0.42% | NEW | — | $35.36 | +6.0% |
| 24 | SEPN | SEPTERNA INC | Healthcare | 1,337,500 | $32.1M | 0.32% | NEW | — | $24.03 | +17.9% |
| 25 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 1,500,000 | $29.3M | 0.29% | NEW | — | $19.56 | -12.9% |
| 26 | GHRS | GH RESEARCH PLC | Healthcare | 1,800,000 | $25.3M | 0.25% | NEW | — | $14.06 | +58.0% |
| 27 | AVTX | AVALO THERAPEUTICS | Healthcare | 1,410,000 | $21.1M | 0.21% | NEW | — | $14.93 | +18.8% |
| 28 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 1,875,000 | $10.8M | 0.11% | NEW | — | $5.74 | -4.2% |
| 29 | UTHR CALL | UNITED THERAPEUTICS CORP | Healthcare | 380,000 | $10.3M | 0.10% | NEW | — | $27.09 | +2025.1% |
| 30 | WHWK | WHITEHAWK THERAPEUTICS INC | Healthcare | 2,849,402 | $9.8M | 0.10% | NEW | — | $3.45 | +47.8% |
| 31 | MNKD | MANNKIND CORP | Healthcare | 2,200,000 | $5.4M | 0.05% | NEW | — | $2.45 | +31.4% |
| 32 | CELC CALL | CELCUITY INC | Healthcare | 200,000 | $3.0M | 0.03% | NEW | — | $15.25 | +802.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%